preclinical studies of tasquinimod in mds: in vitro and in vivo investigations
Published 3 months ago • 85 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
1:17
phase ii study of tosedostat in mds
-
5:43
pre- and post-allohsct treatment in mds
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
2:25
pre-clinical activity of ucartcs1 in multiple myeloma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
8:21:49
hematopathology overview 2023
-
1:26:55
emerging treatments for low-risk mds
-
1:18:54
jtmp webinar: hematology - the royal disease
-
32:12
#5a - pre-eclampsia: toxemia and the devil
-
36:54
introduction to pharmacoepidemiology #2: introduction to everything
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
4:48
an insight into the management of cytopenias in mf
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
6:31
national clinical research center of hematologic diseases
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml